Cerner Has Acquired Labotix Automation Inc.
Combination Will Create the Most Comprehensive Set of Lab Automation Capabilities
KANSAS CITY, Mo. and PETERBOROUGH, Ontario, March 18, 2013 (GLOBE NEWSWIRE) -- Cerner (Nasdaq:CERN) today announced it has acquired Labotix® Automation Inc., a leading provider of flexible, open automation solutions for the clinical laboratory setting.
The combination of Cerner Millennium®, Cerner Copath, and Labotix' Automation will create the most comprehensive set of capabilities on the market to support high volume testing.
Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities. "By aligning Labotix and Cerner® solutions, Cerner is uniquely positioned with its automation options to support clients focusing on increasing laboratory processing capacity while reducing error," said Dr. John David Nolen, Managing Director of Laboratory Medicine for Cerner. "These capabilities are, and increasingly will be, important to organizations which have a business model for high volume or centralized laboratory business models."
Labotix Automation is an open automation solution, meaning it will work with all best of breed devices currently on the market. With installations around the world that have been operating and evolving for more than twenty years, Labotix Automation has the experience, expertise and reliability necessary to meet the needs of any size laboratory.
Since its inception in 1991, Labotix Automation has steadily grown its presence in the laboratory automation market. Cerner, an industry-leading health care company, will immediately offer Labotix Automation solutions to clients around the world and expects to drive increased value for laboratories through integration with Cerner's platforms.
"Cerner's dedication to providing clinical organizations with reliable, flexible and continuous innovation, combined with Labotix' automation solutions will further enable clinical laboratories to increase accuracy and efficiency to deliver better outcomes for individuals," said John Gustafson, CEO of Labotix Automation.
The acquisition is not expected to have a material impact on Cerner's 2013 financial results.
Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we've learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.
Cerner®solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies.
Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq:CERN. For more information about Cerner, please visit www.cerner.com, Twitter, Facebook and YouTube.
This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "will create" "expects" and "is not expected" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our client support facilities; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; risks associated with our non-U.S. operations; risks associated with our recruitment and retention of key personnel; risks related to our dependence on third party suppliers; risks inherent with business acquisitions; changing political, economic, regulatory and judicial influences; government regulation; significant competition and market changes; and, failure to reach the intended synergies. Additional discussion of these and other risks, uncertainties and factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.
CONTACT: Cerner Media Contact: Megan Moriarty, (816) 888-2470, email@example.com Cerner Investors Contact: Allan Kells, (816) 201-2445, firstname.lastname@example.org